When: Close >$1,238 on volume >3.5M shares

Then: Add 1% starter with stop at breakout day's low

HOLD

• Price at $1,234 testing June 29 swing high at $1,238 overhead resistance, not momentum ignition into open air
• $1,160 50 SMA retest is base case, not tail risk - stock just hit $1,109 four trading days ago with ATR at $42.65
• GAAP EPS growth 26-27% vs non-GAAP 27.3% beat - capital structure now leveraged with debt to equity at 162%
• Beta 0.506 defensive characteristics don't protect against cross-asset geopolitical shocks like Strait of Hormuz scenario
• Moat argument valid but justifies owning the position long-term, not adding at 52-week highs with no margin of safety
• Buy trigger at close above $1,238, not pre-positioning before breakout - waiting for confirmation rather than buying the test
• Adding capital at $1,160 at 50 SMA or $1,109 at August low if those levels print, with hard stops and defined sizing

→ vs aggressive: MACD bullish cross and RSI 60.7 constitute momentum ignition - the conservative analyst argues this is actually momentum into a known supply zone where the stock previously failed at $1,238

→ vs aggressive: $1,160 levels may never come - the conservative analyst argues this is FOMO logic; the stock just hit $1,109 four days ago and a 6% pullback to 50 SMA is less than one standard deviation move given ATR at $42.65

→ vs aggressive: Non-GAAP earnings quality justifies current valuation - the conservative analyst argues forward P/E embedded with 56% EPS growth will recalculate if Street estimates rise, and 26-27% GAAP EPS growth is the legally reported figure

→ vs aggressive: Absence of retail euphoria on StockTwits means not crowded - the conservative analyst argues absence of data feed is not absence of crowding, this is an argument from silence not confirmation

→ vs aggressive: Low beta provides macro protection - the conservative analyst argues defensive beta works on the way down only when the catalyst is contained, and Strait of Hormuz is a cross-asset shock

→ vs aggressive: Moat and manufacturing capacity justify aggressive positioning - the conservative analyst concedes the moat is real but argues it justifies owning the position, not adding at resistance

→ vs aggressive: $3.5 billion special charges should be stripped out - the conservative analyst argues these represent real capital deployment: $8.75 billion acquisitions, $3.28 billion intangibles, financed with $11.58 billion net new debt

→ vs aggressive: Breakout call - treating close above $1,238 as buy trigger - the conservative analyst argues this is pre-positioning before confirmation, buying the test not the resolution

HOLD with modified add framework; add 1% on confirmed breakout above $1,238 with 3.5M+ volume, otherwise add only on pullbacks to $1,160 or $1,109

• V-shaped recovery of 11% in four sessions on rising volume with RSI at 60.7 and fresh MACD bullish crossover
• Fundamental catalyst stack: 47.7% revenue beat, 27.3% EPS beat, raised guidance to $86 billion, first European oral GLP-1 approval, FDA Breakthrough Therapy designation
• Revenue accelerating from +42% in Q3 2025 to +47.7% in Q2 2026 supports high-30s to mid-40s growth for next 2-3 quarters
• Forward P/E of 26.5x embeds continued execution at current growth rate, more defensible than conservative framing but vulnerable to any Q3/Q4 deceleration
• Beta of 0.506 and defensive GLP-1 cash flows make LLY a relative beneficiary in risk-off, but drawdown would not be zero in cross-asset shock
• Resistance at $1,234-$1,238 is a retest of June 29 swing high that previously failed, creating unresolved binary outcome
• 50 SMA at $1,160 represents base case pullback target (6% away, less than two ATR moves)
• Information gap on crowding levels means unknown should be treated as unknown, not assumed negative
• Compounding high-quality LLY position through volatility generates more return than trading around short-term moves
• Add framework: keep existing $1,160 and $1,109 pullback levels, add confirmation-based breakout tier at 1% if daily close above $1,238 with 3.5M+ volume

→ vs aggressive: Pre-positioning at $1,232 puts capital at risk in known supply zone with unresolved binary; should wait for confirmed close above $1,238

→ vs aggressive: Treating every HOLD as a binary opportunity lost ignores long-term compounding benefits of holding quality names through volatility

→ vs aggressive: Conflicting 'momentum ignition' and 'testing major resistance' as if they can coexist without tension; MACD crossover consistent with both breakout and false breakout scenarios

→ vs conservative: Assuming crowding exists from absence of StockTwits data treats an unknown as a known negative; must size smaller for information gap rather than assume worst

→ vs conservative: Breakout scenario is a real outcome deserving planned response, not a tail event to ignore; pretending $1,238 will reject with certainty is overconfident